Table 1.

Individual patient characteristics, bariatric surgery-related and IBD-related outcomes from UNC cohort

Patient	Age, years	Sex	IBD type	IBDphenotype	Prior IBD surgery	Preop. IBD medications	Preop. BMI	Surgery type	6 monthspostop. BMI	12 monthspostop. BMI	Early postop. complications	Late postop. complications	Postop. IBD medications	Postop. IBD flare
1	39	F	CD	A2L1B1	None	Adalimumab	43.91	SG	31.28	28.94	None	None	No changes	No
2	52	M	CD	A3L2B1	None	None	42.16	SG	31.65	31.78	None	None	No medications	No
3	56	F	CD	N/A	SBR	Thiopurine	36.77	SG	30.15	31.20	None	None	No changes	No
4	49	F	CD	A3L1B3	SBR	5-ASA	44.39	SG	30.91	26.41	None	None	No changes	No
5	40	F	CD	A2L2B3	IBD-related Surgery	Adalimumab, Thiopurine	36.58	SG	32.38	31.14	None	None	Stopped thiopurine	No
6	36	F	CD	N/A	None	None	61.54	SG	50.36	42.60	N&V	None	No medications	No
7	45	F	CD	N/A	SBR	5-ASA	40.91	SG	28.90	25.38	None	None	Medications discontinued	No
8	69	F	CD	N/A	SBR	None	60.41	RYGB	44.95	34.02	N&V	N&V	No medications	No
9	54	F	CD	N/A	None	None	42.75	SG	32.54	31.24	None	None	No medications	No
10	41	F	UC	A3E2	TAC w/IPAA	None	42.78	RYGB	32.75	N/A	SBO, N&V	Incisional abscess	No medications	No
11	37	F	UC	A2E3	TAC w/EI	None	42.51	LAGB	36.84	33.93	N&V, stenosis	Band slippage	No medications	No
12	42	F	UC	A3E3	None	5-ASA, Thiopurine	45.58	RYGB	35.17	N/A	N&V	None	N/A	No
13	65	M	UC	A3E1	None	None	39.77	SG	33.90	N/A	None	None	No medications	No
Mean (SE)	48.1 (2.9)						44.6 (2.1)		34.8 (1.7)	31.7 (1.5)

EI, end ileostomy; IPAA, ileo-anal pouch anastomosis; N&V, nausea and vomiting; SBO, small bowel obstruction; SBR, small bowel resection; TAC, total abdominal colectomy.